Short answer · Medically reviewed summary · Last updated: 2026-05-08
Currently, there is no medical cure for Costello Syndrome, a rare genetic disorder caused by activating mutations in the HRAS gene. While researchers are actively investigating the underlying molecular pathways, treatment remains focused on multidisciplinary symptom management to improve quality of life and address the specific health challenges associated with Costello Syndrome. How is Costello Syndrome managed today? Because Costello Syndrome affects multiple organ systems, care is managed by a team of specialists including cardiologists, endocrinologists, and oncologists.
Does Costello Syndrome have a cure?
Is there a cure for Costello Syndrome? Current treatment landscape and research progress, medically reviewed, plus patient experiences.
Currently, there is no medical cure for Costello Syndrome, a rare genetic disorder caused by activating mutations in the HRAS gene. While researchers are actively investigating the underlying molecular pathways, treatment remains focused on multidisciplinary symptom management to improve quality of life and address the specific health challenges associated with Costello Syndrome.
How is Costello Syndrome managed today?
Because Costello Syndrome affects multiple organ systems, care is managed by a team of specialists including cardiologists, endocrinologists, and oncologists. Current treatments focus on addressing cardiac issues like hypertrophic cardiomyopathy, managing feeding difficulties, and performing regular cancer screenings, as individuals with Costello Syndrome have an increased risk of developing specific tumors, such as rhabdomyosarcoma.
What research is being done to find a cure for Costello Syndrome?
Clinical researchers are exploring precision medicine approaches to target the RAS/MAPK pathway, which is overactive in Costello Syndrome. Current research efforts include:
- Targeted Therapies: Evaluating MEK inhibitors to potentially modulate the overactive signaling pathways that drive the clinical features of the syndrome.
- Natural History Studies: Ongoing long-term studies to better understand the progression of Costello Syndrome, which is essential for designing future clinical trials.
- Biomarker Discovery: Identifying specific molecular markers that could help predict disease severity and response to potential future therapies.
What is the timeline for new treatments?
While experimental therapies for Costello Syndrome are being studied in laboratory settings and some clinical trials, there is no definitive timeline for a breakthrough. Drug development is a rigorous process, and the rarity of the condition—affecting approximately 1 in 300,000 to 1 in 1.25 million people—makes large-scale clinical trials challenging. However, the global medical community is increasingly focused on RASopathies, providing hope for more targeted interventions.
Next steps
- Consult with a geneticist to discuss the specific HRAS mutation present in your family.
- Join the 13 members of the Costello Syndrome community at DiseaseMaps.org to share experiences and stay updated on research.
- Monitor ClinicalTrials.gov for updates on emerging studies related to RASopathies.
- Connect with the Costello Syndrome Family Network for support and access to the latest physician-reviewed literature.
Medical disclaimer: This information is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases (GARD) Information Center: Costello Syndrome
- Orphanet: Costello Syndrome (ORPHA:206)
- OMIM (Online Mendelian Inheritance in Man): HRAS-Related Disorders
- Costello Syndrome Family Network (CSFN)
